ARR vs PLD

The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score, raising transparency concerns. Despite a high dividend yield of 15.62%, the unsustainable payout ratio of 1515.79% and deteriorating earnings (YoY EPS decline of 28.0%) signal severe dividend risk. Valuation metrics are mixed: while the P/B of 0.97 suggests near-book value, the sky-high P/E of 96.63 and negative earnings surprises over the last four quarters imply overvaluation relative to performance. Insider selling, weakening profitability trends, and aggressive leverage (Debt/Equity: 7.81) further undermine confidence in the current price level.

PLD exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong fundamental momentum. The stock is trading at a severe premium, with a current price of $139.77 far exceeding both the Graham Number ($67.96) and the Intrinsic Value ($59.06). While the company maintains dominant market margins and a healthy debt-to-equity ratio, the unsustainable dividend payout ratio of 113.48% and an astronomical PEG ratio of 108.01 signal extreme overvaluation. Technical trends and insider selling further reinforce a bearish outlook despite analyst 'buy' ratings.